Silver Book Fact

Randomized controlled trials give evidence that pharmacologic therapy can reduce risk of fractures by 40 to 50%.

Papaioannou A, Watts N, Kendler D, et al. Diagnosis and Management of Vertebral Fractures in Elderly Adults. Am J Med. 2002; 113(3): 220-8. http://www.amjmed.com/article/S0002-9343(02)01190-7/abstract

Reference

Title
Diagnosis and Management of Vertebral Fractures in Elderly Adults
Publication
Am J Med
Publication Date
2002
Authors
Papaioannou A, Watts N, Kendler D, et al
Volume & Issue
Volume 113, Issue 3
Pages
220-8
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Risedronate, a bisphosphonate, has been shown to reduce vertebral fractures by around 41%, hip fractures by 30%, and non-vertebral fractures by 39%.  
  • Alendronate, a bisphosphonate, has been shown to reduce risk of hip fracture by around 53%, clinical vertebral fracture by 45%, and wrist fracture by 30%.  
  • Hip fracture prevention in at-risk, postmenopausal women saves $333 million annually.  
  • A systematic review of osteoporosis therapies found good evidence that many are effective in preventing fractures, but concluded that the data are insufficient to determine if any one therapy is…  
  • Genetics can account for up to 75% of bone mineral density (BMD). Researchers have identified a gene that strongly influences peak bone mass in mice. The gene was not previously…